Brief: Immunocore Announces Clinical Trial Collaboration And Supply Agreement With Bristol Myers Squibb

Immunocore Holdings

22/02/2024 14:19

Feb 22 (Reuters) - Immunocore Holdings PLC  IMCR.O :
    * IMMUNOCORE ANNOUNCES CLINICAL TRIAL COLLABORATION AND
SUPPLY
AGREEMENT WITH BRISTOL MYERS SQUIBB TO EVALUATE IMC-F106C (PRAME
HLA-A02) IN COMBINATION WITH NIVOLUMAB IN ITS REGISTRATIONAL
PHASE 3 FIRST-LINE ADVANCED CUTANEOUS MELANOMA TRIAL

Source text for Eikon:  ID:nGNX3805Jv 
Further company coverage:  IMCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))